Skip to main content
Erschienen in: Tumor Biology 11/2015

01.11.2015 | Research Article

Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy

verfasst von: An-Chuan Li, Wei-Wei Xiao, Lin Wang, Guan-Zhu Shen, An-An Xu, Yan-Qing Cao, Shao-Min Huang, Cheng-Guang Lin, Fei Han, Xiao-Wu Deng, Chong Zhao

Erschienen in: Tumor Biology | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study is to identify the risk factors and construct a prediction-score model for distant metastasis (DM) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). A total of 520 nonmetastatic NPC patients were analysed retrospectively. The independent risk factors for DM were tested by multivariate Cox regression analysis. The prediction-score model was established according to the regression coefficient. The median follow-up was 88.4 months. The 5-year DM rate was 15.1 %. N2–3, primary tumour volume of nasopharynx (GTVnx) >24.56 cm3, haemoglobin change after treatment (ΔHGB) >25.8 g/L, albumin-globulin ratio (AGR) ≤1.34, pretreatment neutrophil-lymphocyte ratio (NLR) >2.81 and pretreatment serum lactate dehydrogenase (LDH) >245 U/L were significantly adverse independent predictive factors for DM. Three subgroups were defined based on the prediction-score model: low risk (0–2), intermediate risk (3–4) and high risk (5–8). The 5-year DM rates were 4.6, 21.8 and 50.8 %, respectively (P < 0.001). The areas under the curve for DM in the prediction-score model and the UICC/AJCC staging system seventh edition were 0.748 and 0.627, respectively (P < 0.001). The scoring model is useful in evaluating the risk of DM in IMRT-treated NPC patients and guiding future therapeutic trials. Further prospective study is needed.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421–9.CrossRefPubMed Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421–9.CrossRefPubMed
2.
Zurück zum Zitat Zhao C, Xiao W, Han F, Lu L, Wu S, et al. Long-term outcome and prognostic factors of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Chin J Radiat Oncol. 2010;19:191–6. Zhao C, Xiao W, Han F, Lu L, Wu S, et al. Long-term outcome and prognostic factors of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Chin J Radiat Oncol. 2010;19:191–6.
3.
Zurück zum Zitat Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440–50.CrossRefPubMed Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440–50.CrossRefPubMed
4.
Zurück zum Zitat Lee N, Harris J, Garden AS, Straube W, Glisson B, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27:3684–90.CrossRefPubMedPubMedCentral Lee N, Harris J, Garden AS, Straube W, Glisson B, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27:3684–90.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Ng WT, Lee MC, Hung WM, Choi CW, Lee KC, et al. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2011;79:420–8.CrossRefPubMed Ng WT, Lee MC, Hung WM, Choi CW, Lee KC, et al. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2011;79:420–8.CrossRefPubMed
6.
Zurück zum Zitat Sun X, Su S, Chen C, Han F, Zhao C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110:398–403.CrossRefPubMed Sun X, Su S, Chen C, Han F, Zhao C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110:398–403.CrossRefPubMed
7.
Zurück zum Zitat Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B, et al. Nasopharyngeal carcinoma: the next challenges. Eur J Cancer. 2010;46:1967–78.CrossRefPubMed Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B, et al. Nasopharyngeal carcinoma: the next challenges. Eur J Cancer. 2010;46:1967–78.CrossRefPubMed
8.
Zurück zum Zitat Bensouda Y, Kaikani W, Ahbeddou N, Rahhali R, Jabri M, et al. Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:79–85.CrossRefPubMed Bensouda Y, Kaikani W, Ahbeddou N, Rahhali R, Jabri M, et al. Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:79–85.CrossRefPubMed
9.
Zurück zum Zitat Yu E, O'Sullivan B, Kim J, Siu L, Bartlett E. Magnetic resonance imaging of nasopharyngeal carcinoma. Expert Rev Anticancer Ther. 2010;10:365–75.CrossRefPubMed Yu E, O'Sullivan B, Kim J, Siu L, Bartlett E. Magnetic resonance imaging of nasopharyngeal carcinoma. Expert Rev Anticancer Ther. 2010;10:365–75.CrossRefPubMed
10.
Zurück zum Zitat Lee N, Xia P, Quivey JM, Sultanem K, Poon I, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12–22.CrossRefPubMed Lee N, Xia P, Quivey JM, Sultanem K, Poon I, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12–22.CrossRefPubMed
11.
Zurück zum Zitat Qiu MZ, Xu RH, Ruan DY, Li ZH, Luo HY, et al. Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol. 2010;31:633–41.CrossRefPubMed Qiu MZ, Xu RH, Ruan DY, Li ZH, Luo HY, et al. Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol. 2010;31:633–41.CrossRefPubMed
12.
Zurück zum Zitat Zhou GQ, Tang LL, Mao YP, Chen L, Li WF, et al. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis. Int J Radiat Oncol Biol Phys. 2012;82:e359–65.CrossRefPubMed Zhou GQ, Tang LL, Mao YP, Chen L, Li WF, et al. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis. Int J Radiat Oncol Biol Phys. 2012;82:e359–65.CrossRefPubMed
13.
Zurück zum Zitat Xiao WW, Huang SM, Han F, Wu SX, Lu LX, et al. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer. 2011;117:1874–83.CrossRefPubMed Xiao WW, Huang SM, Han F, Wu SX, Lu LX, et al. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer. 2011;117:1874–83.CrossRefPubMed
14.
Zurück zum Zitat WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
15.
Zurück zum Zitat McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005. Public Health Nutr. 2009;12:444–54.CrossRefPubMed McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005. Public Health Nutr. 2009;12:444–54.CrossRefPubMed
16.
Zurück zum Zitat Wu Z, Su Y, Zeng RF, Gu MF, Huang SM. Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy. J Cancer Res Clin Oncol. 2014;140:69–76.CrossRefPubMed Wu Z, Su Y, Zeng RF, Gu MF, Huang SM. Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy. J Cancer Res Clin Oncol. 2014;140:69–76.CrossRefPubMed
17.
Zurück zum Zitat Lee CC, Huang TT, Lee MS, Hsiao SH, Lin HY, et al. Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome. Radiat Oncol. 2010;5:20.CrossRefPubMedPubMedCentral Lee CC, Huang TT, Lee MS, Hsiao SH, Lin HY, et al. Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome. Radiat Oncol. 2010;5:20.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Guo R, Sun Y, Yu XL, Yin WJ, Li WF, et al. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma? Radiother Oncol. 2012;104:294–9.CrossRefPubMed Guo R, Sun Y, Yu XL, Yin WJ, Li WF, et al. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma? Radiother Oncol. 2012;104:294–9.CrossRefPubMed
19.
Zurück zum Zitat Chua DT, Sham JS, Kwong DL, Tai KS, Wu PM, et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys. 1997;39:711–9.CrossRefPubMed Chua DT, Sham JS, Kwong DL, Tai KS, Wu PM, et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys. 1997;39:711–9.CrossRefPubMed
20.
Zurück zum Zitat Chen MK, Chen TH, Liu JP, Chang CC, Chie WC. Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume. Cancer. 2004;100:2160–6.CrossRefPubMed Chen MK, Chen TH, Liu JP, Chang CC, Chie WC. Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume. Cancer. 2004;100:2160–6.CrossRefPubMed
21.
Zurück zum Zitat Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27:131–46.CrossRefPubMed Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27:131–46.CrossRefPubMed
22.
Zurück zum Zitat Johnson CR, Thames HD, Huang DT, Schmidt-Ullrich RK. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int J Radiat Oncol Biol Phys. 1995;33:281–7.CrossRefPubMed Johnson CR, Thames HD, Huang DT, Schmidt-Ullrich RK. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int J Radiat Oncol Biol Phys. 1995;33:281–7.CrossRefPubMed
23.
Zurück zum Zitat Lartigau E, Le Ridant AM, Lambin P, Weeger P, Martin L, et al. Oxygenation of head and neck tumors. Cancer. 1993;71:2319–25.CrossRefPubMed Lartigau E, Le Ridant AM, Lambin P, Weeger P, Martin L, et al. Oxygenation of head and neck tumors. Cancer. 1993;71:2319–25.CrossRefPubMed
24.
Zurück zum Zitat Okunieff P, Hoeckel M, Dunphy EP, Schlenger K, Knoop C, et al. Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys. 1993;26:631–6.CrossRefPubMed Okunieff P, Hoeckel M, Dunphy EP, Schlenger K, Knoop C, et al. Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys. 1993;26:631–6.CrossRefPubMed
25.
Zurück zum Zitat Yaes RJ. Tumor heterogeneity, tumor size, and radioresistance. Int J Radiat Oncol Biol Phys. 1989;17:993–1005.CrossRefPubMed Yaes RJ. Tumor heterogeneity, tumor size, and radioresistance. Int J Radiat Oncol Biol Phys. 1989;17:993–1005.CrossRefPubMed
26.
Zurück zum Zitat Bentzen SM, Johansen LV, Overgaard J, Thames HD. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 1991;20:1197–206.CrossRefPubMed Bentzen SM, Johansen LV, Overgaard J, Thames HD. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 1991;20:1197–206.CrossRefPubMed
27.
Zurück zum Zitat Hill RP, De Jaeger K, Jang A, Cairns R. PH, hypoxia and metastasis. Novartis Found Symp. 2001;240:154–65.CrossRefPubMed Hill RP, De Jaeger K, Jang A, Cairns R. PH, hypoxia and metastasis. Novartis Found Symp. 2001;240:154–65.CrossRefPubMed
28.
Zurück zum Zitat De Jaeger K, Merlo FM, Kavanagh MC, Fyles AW, Hedley D, et al. Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. Int J Radiat Oncol Biol Phys. 1998;42:717–21.CrossRefPubMed De Jaeger K, Merlo FM, Kavanagh MC, Fyles AW, Hedley D, et al. Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. Int J Radiat Oncol Biol Phys. 1998;42:717–21.CrossRefPubMed
29.
Zurück zum Zitat Huang PY, Wang CT, Cao KJ, Guo X, Guo L, et al. Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: findings from a randomised trial. Eur J Cancer. 2013;49:1923–31.CrossRefPubMed Huang PY, Wang CT, Cao KJ, Guo X, Guo L, et al. Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: findings from a randomised trial. Eur J Cancer. 2013;49:1923–31.CrossRefPubMed
30.
Zurück zum Zitat Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr. 2014;99:999–1005.CrossRefPubMed Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr. 2014;99:999–1005.CrossRefPubMed
31.
Zurück zum Zitat Gao J, Tao YL, Li G, Yi W, Xia YF. Involvement of difference in decrease of hemoglobin level in poor prognosis of stage I and II nasopharyngeal carcinoma: implication in outcome of radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82:1471–8.CrossRefPubMed Gao J, Tao YL, Li G, Yi W, Xia YF. Involvement of difference in decrease of hemoglobin level in poor prognosis of stage I and II nasopharyngeal carcinoma: implication in outcome of radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82:1471–8.CrossRefPubMed
32.
Zurück zum Zitat Chang H, Gao J, Xu BQ, Guo SP, Lu RB, et al. Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution. Clin Oncol (R Coll Radiol). 2013;25:639–46.CrossRef Chang H, Gao J, Xu BQ, Guo SP, Lu RB, et al. Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution. Clin Oncol (R Coll Radiol). 2013;25:639–46.CrossRef
33.
Zurück zum Zitat Wan S, Lai Y, Myers RE, Li B, Palazzo JP, et al. Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies—results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers. BMC Cancer. 2013;13:340.CrossRefPubMedPubMedCentral Wan S, Lai Y, Myers RE, Li B, Palazzo JP, et al. Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies—results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers. BMC Cancer. 2013;13:340.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Grotto HZ. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med Oncol. 2008;25:12–21.CrossRefPubMed Grotto HZ. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med Oncol. 2008;25:12–21.CrossRefPubMed
36.
Zurück zum Zitat Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.CrossRefPubMedPubMedCentral Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Li G, Gao J, Liu ZG, Tao YL, Xu BQ, et al. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: long-term outcomes of 512 patients from a single institution. Head Neck. 2014;36:660–6.CrossRefPubMed Li G, Gao J, Liu ZG, Tao YL, Xu BQ, et al. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: long-term outcomes of 512 patients from a single institution. Head Neck. 2014;36:660–6.CrossRefPubMed
38.
Zurück zum Zitat Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med. 2004;350:2461–70.CrossRefPubMed Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med. 2004;350:2461–70.CrossRefPubMed
39.
Zurück zum Zitat Gourzones C, Barjon C, Busson P. Host-tumor interactions in nasopharyngeal carcinomas. Semin Cancer Biol. 2012;22:127–36.CrossRefPubMed Gourzones C, Barjon C, Busson P. Host-tumor interactions in nasopharyngeal carcinomas. Semin Cancer Biol. 2012;22:127–36.CrossRefPubMed
40.
Zurück zum Zitat An X, Ding PR, Wang FH, Jiang WQ, Li YH. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol. 2011;32:317–24.CrossRefPubMed An X, Ding PR, Wang FH, Jiang WQ, Li YH. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol. 2011;32:317–24.CrossRefPubMed
42.
Zurück zum Zitat Li G, Gao J, Tao YL, Xu BQ, Tu ZW, et al. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin J Radiat Oncol. 2012;31:197–206. Li G, Gao J, Tao YL, Xu BQ, Tu ZW, et al. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin J Radiat Oncol. 2012;31:197–206.
43.
Zurück zum Zitat Jin Y, Cai XY, Cai YC, Cao Y, Xia Q, et al. To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area. Eur J Cancer. 2012;48:882–8.CrossRefPubMed Jin Y, Cai XY, Cai YC, Cao Y, Xia Q, et al. To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area. Eur J Cancer. 2012;48:882–8.CrossRefPubMed
44.
Zurück zum Zitat Wang W, Feng M, Fan Z, Li J, Lang J. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Biomed Res Int. 2014;2014:814948.PubMedPubMedCentral Wang W, Feng M, Fan Z, Li J, Lang J. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Biomed Res Int. 2014;2014:814948.PubMedPubMedCentral
45.
Zurück zum Zitat Cheng SH, Tsai SY, Horng CF, Yen KL, Jian JJ, et al. A prognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:992–1003.CrossRefPubMed Cheng SH, Tsai SY, Horng CF, Yen KL, Jian JJ, et al. A prognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:992–1003.CrossRefPubMed
46.
Zurück zum Zitat Tang LQ, Chen QY, Fan W, Liu H, Zhang L, et al. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol. 2013;31:2861–9.CrossRefPubMed Tang LQ, Chen QY, Fan W, Liu H, Zhang L, et al. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol. 2013;31:2861–9.CrossRefPubMed
Metadaten
Titel
Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
verfasst von
An-Chuan Li
Wei-Wei Xiao
Lin Wang
Guan-Zhu Shen
An-An Xu
Yan-Qing Cao
Shao-Min Huang
Cheng-Guang Lin
Fei Han
Xiao-Wu Deng
Chong Zhao
Publikationsdatum
01.11.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 11/2015
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3574-0

Weitere Artikel der Ausgabe 11/2015

Tumor Biology 11/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.